<DOC>
	<DOCNO>NCT00192192</DOCNO>
	<brief_summary>To perform variety assay blood , serum , nasal wash sample cell obtain healthy adult subject purpose develop assay application investigation immune response generate influenza virus vaccine , trivalent , type A B , live , cold-adapted ( liquid CAIV-T ; Wyeth Lederle Vaccines , Marietta , PA ) .</brief_summary>
	<brief_title>Trial Investigate Immune Responses Elicited Liquid Formulation Influenza Virus Vaccine , Trivalent , Types A &amp; B , Live Cold Adapted ( CAIV-T ) Healthy Adults</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<criteria>18 64 year age . Subject must least 18 year age old 64 year age time inform consent obtain ; eligible female subject , childbearing potential , negative urine pregnancy test result prior study vaccination . Females surgically sterile postmenopausal require pregnancy test . determine medical history , physical examination clinical judgement eligible study . Subjects stable preexist disease , define disease require change therapy hospitalization within 12 week receipt study vaccination eligible . provide write informed consent nature study explain ; , available two month duration trial ( enrollment study completion ) ; reach study staff postvaccination contact [ telephone , clinic home visit ] perceive unavailable difficult contact evaluation study visit study period know suspected disease immune system receive immunosuppressive therapy , include systemic corticosteroid ; cytotoxic agent ; receive blood product , include immunoglobulin , period six month prior vaccination conclusion study ; immunosuppressed immunocompromised individual living household ; document history hypersensitivity egg egg protein component study vaccine placebo ; administer live virus vaccine within one month prior enrollment ; intent administer investigational vaccine agent one month prior enrollment conclusion study ; , receive dose influenza treatment ( commercial investigational ) one month prior enrollment . The prophylactic use influenza antiviral permit . receive influenza vaccine 6 month prior enrollment , nonstudy influenza vaccine since enrollment ; medical condition opinion investigator might interfere interpretation study result ; Note : A pregnant household member consider contraindication enrollment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>October 2006</verification_date>
</DOC>